Edmund Harrigan

Director/Board Member at ACADIA PHARMACEUTICALS INC.

Net worth: 4 M $ as of 2026-09-29

73 year

95 connections

Health Technology

Consumer Services

Technology Services

Profile

Edmund P.
Harrigan is currently an Independent Director at Incyte Corp.
since 2019, ACADIA Pharmaceuticals, Inc. since 2015, and AlgoTherapeutix SAS since 2021.
Former positions include Independent Director at Bellicum Pharmaceuticals, Inc. from 2018 to 2019, Independent Non-Executive Director at Karuna Therapeutics, Inc. from 2011 to 2020, Director at Lyndra Therapeutics, Inc., Independent Director at PhaseBio Pharmaceuticals, Inc. from 2018 to 2023, and Senior VP-Worldwide Safety & Regulatory at Pfizer Inc. from 2012 to 2015.
Education includes an undergraduate degree from St. Anselm College in 1974 and a doctorate from UMass Chan Medical School in 1979.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
INCYTE CORPORATION 0.01%	2026-09-29	23,225 ( 0.01% )	3 M $	2026-09-29
ACADIA PHARMACEUTICALS INC. 0.03%	2026-05-28	43,148 ( 0.03% )	869 432 $	2026-09-29

Edmund Harrigan active positions

Companies	Position	Start
ACADIA PHARMACEUTICALS INC.	Director/Board Member	2015-11-24
INCYTE CORPORATION	Director/Board Member	2019-12-15
Algotherapeutix SAS Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies	Director/Board Member	2021-04-12

All active positions of Edmund Harrigan

Former positions of Edmund Harrigan

Companies	Position	End
PHASEBIO PHARMACEUTICALS, INC.	Director/Board Member	2022-12-31
KARA THER	Director/Board Member	2020-12-02
BELLICUM PHARMACEUTICALS, INC.	Director/Board Member	2019-12-18
PFIZER INC.	General Counsel	2015-06-30
Lyndra Therapeutics, Inc. Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Develops oral drug delivery platform	Director/Board Member	-

See the detail of Edmund Harrigan's experience

Education of Edmund Harrigan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Edmund Harrigan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Incyte Corp. Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics	Health Technology
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
ACADIA Pharmaceuticals, Inc. ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders	Health Technology
PhaseBio Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases	Health Technology
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer	Health Technology
St. Anselm College St. Anselm College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
UMass Chan Medical School UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Karuna Therapeutics, Inc. Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease	Health Technology
Lyndra Therapeutics, Inc. Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Develops oral drug delivery platform	Technology Services
Algotherapeutix SAS Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies	Health Technology